1. Home
  2. GSM vs MLTX Comparison

GSM vs MLTX Comparison

Compare GSM & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.81

Market Cap

920.1M

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.76

Market Cap

979.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
MLTX
Founded
2015
2021
Country
United Kingdom
Switzerland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
920.1M
979.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GSM
MLTX
Price
$4.81
$15.76
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$6.00
$22.22
AVG Volume (30 Days)
1.1M
3.6M
Earning Date
02-18-2026
02-25-2026
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,373,244,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$5.95
52 Week High
$5.74
$62.75

Technical Indicators

Market Signals
Indicator
GSM
MLTX
Relative Strength Index (RSI) 47.27 52.85
Support Level $4.86 $15.20
Resistance Level $5.30 $16.57
Average True Range (ATR) 0.25 1.19
MACD -0.04 -0.06
Stochastic Oscillator 12.59 22.36

Price Performance

Historical Comparison
GSM
MLTX

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: